Please assess the completion status of the following clinical trial:

Trial Title: TOM: Testosterone in Older Men With Sarcopenia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Community dwelling, ages 65 and older~* Self-reported difficulty in climbing 10 steps without resting, or difficulty in walking 2 or 3 blocks outside on level ground~* A score of 4 to 9 on the Short Physical Performance Battery (mild to moderate physical impairment)~* Total serum testosterone level (TT) \< 350 ng/dL and \> 100 ng/dL~* Without dementia (Mini-Mental State Examination \[MMSE\] score \> 24)~Exclusion Criteria:~* Use of testosterone, anabolic steroids, dehydroepiandrosterone (DHEA), androstenedione or recombinant growth hormone (rGH) in the past year~* Alcohol or drug abuse~* Use of anti-convulsants or glucocorticoids (equivalent to prednisone \> 20 mg/day)~* Prostate cancer, breast cancer or other cancers with life expectancy \< 5 years~* Limiting neuromuscular, joint or bone disease, or history of stroke with residual neurological problems~* Any neurological condition that would impact cognitive functioning including:~  * epilepsy~ * multiple sclerosis~ * HIV~ * Parkinson's disease~ * stroke~ * other focal lesion~* Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) Axis I psychiatric disorder in past year or use of psychotropic medications in 6 months~* Abnormal prostate examination; PSA \> 4 ng/mL; or BPH symptom score \> 21~* Unstable angina, New York (NY) class III or IV congestive heart failure or myocardial infarction within 3 months of entry~* Abnormal laboratory values (at discretion of principal investigator)~* Untreated thyroid disease; systolic blood pressure \> 160 or diastolic \> 100 mm Hg~* Body mass index \> 40 kg/m2~* Untreated severe obstructive sleep apnea

- Gender: MALE
- Minimum Age: 65 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Treatment (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).